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Microsurgical Lymph Node Dissection for Metastatic Asymptomatic
C-Cell Carcinoma

Heinz J. Buhr,* Friedrich Kallinowski,* Friedhelm Raue,+ and Christian Herfarth'
In persistent, clinically Inapparent medullary thyroid carcinoma, microsurgical dissection of all
lymph node compartments ofthe neck was performed. Beti'een August 1988 and September 1991,28
cases (mean age 43.3 years) were treated with 38 .surgical interventions. Twenty patients had the
sporadic form and eight patients the famdial form. Unilateral neck dissection resulted in normalization ofserum calcitonin (CT) levels even after pentagastrin stimulation in two patients whereas
16 patients exhibited abnormal CT stimulation tests. Eight of ten patients who had bilateral neck
dissections had positive pentagastrin test results after surgery. The main postoperative complications
included loss of local cutaneous sensation, generally temporary, and unilateral recurrent laryngeal
nerve paralysis. (Henry Ford Hosp Med J1992:40:268-70)

A

pproximately 30 new cases of medullary thyroid carcinoma (MTC) are observed per 1 million population in the
Federal Republic of Germany. MTC, representing between 5%
and 10% ofthe malignant diseases of the thyroid, is a relatively
rare disease. However, it exhibits several unique biological features. The surgical treatment of metastasizing but clinically occult MTC is based on these biological features:
1. Early metastases are noted in regional lymph nodes of the
neck and the mediastinal area, followed by a long interval before
distant metastases become obvious (1). During family screening, Wells et al (2) detected lymph node metastases in 50% of
the patients with elevated basal calcitonin (CT) levels. In patients with clinically detectable tumor masses, this rate increased to 7f%.
2. The node status is of prognostic relevance (3-5). The classic data by Woolner et al (6) indicate 10-year survival rates of
85% in patients without lymph node metastases, which is not
significantly different from that of an apparently healthy cohort.
In patients with lymph node metastases, survival dropped significandy to 42%.
3. MTC is almost radio- and drug-resistant.
The only potentially curative therapeutic modality is the complete surgical removal of tumor tissue including diseased regional lymph nodes. Consequently, Tisell et al (7) introduced
the en-bloc-dissection of the lymphatic tissue of the neck and
mediastinal area into the therapy of MTC. Using this method
and employing microsurgical techniques, all lymph node compartments ofthe central and lateral neck areas and the mediastinal lymphatic tissue are removed.

Methods
In our study, all 28 patients exhibited occult metastases in regional neck lymph nodes as demonstrated by abnormal basal or
pentagastrin-stimulated CT levels. Imaging techniques (ultra-
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sound, computed tomography) failed to visualize the involved
lymph nodes. Preoperatively, selective venous catheterization
was performed. Using this technique (8), a concentration peak
indicative of the site of CT production was obtained suggesting
which side of the neck to perform the primary microdissection
using Tisell et al's method (7). A complete dissection of all lymphatic tributaries sparing the carotid artery, the jugular vein, and
all nerves was achieved with the help of microsurgical techniques. During a single operative session, only one side of the
neck was dissected in order to avoid an excessive duration of
surgery (9). The mean time required for an operation was 6
hours (range 4 to 8 hours). The anatomical landmarks for the
dissection included laterally the edge of the trapezius muscle,
proximally the mandible or dorsally the occiput, caudally the
subclavian vein, and towards the mediastinum the brachiocephalic vein.

Patients
Between August 1988 and September 1991, we treated 28 patients (15 males, 13 females) with persistendy occult MTC using these techniques. The mean age was approximately 43 years
(range 14 to 65 years). A total of 38 neck dissections were performed on these 28 patients. Twenty patients had sporadic MTC
and eight had familial MTC (multiple endocrine neoplasia type
2 [MEN 2] syndrome). A total of 28 neck dissections were performed in the 20 patients with the sporadic form (mean age 47
years). The average interval between primary thyroidectomy
andthe microsurgical lymph node dissection was 1.1 years. The
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eight MEN 2 patients (mean age 34.5 ± 6 years) had 10 surgical
interventions with a mean interval between thyroidectomy and
lymph node dissection of 6.2 years. A cure is defined as a normal CT value after pentagastrin stimulation.

Table
Lymph Node Compartments Found to be Involved
After 38 Microsurgical Neck Dissections
Calcitonin*

Results
Unilateral neck dissection/sporadic form
One of 12 patients with sporadic MTC was cured. Eleven patients exhibit persistently elevated serum CT values, some basally and some only after pentagastrin stimulation.
Unilateral neck dissection/MEN 2
One of six MEN 2 patients had a normal CT response after
stimulation whereas five patients exhibited a pathological elevation.
In the 16 sporadic and MEN 2 patients with abnormal postoperative pentagastrin stimulation tests, basal semm CT concentrations were normal in 12 patients (up to 0.3 p.g/L); two patients
had values below 0.1 p.g/L; and 10 patients had values between
O.I and 0.3 \xg/L. Slightly elevated basal serum CT levels were
observed in four patients.

Compartment
Central
Lateral
Mediastinal

Within Normal Limits
2
2
2

Elevated
21
18
15

*Calcitonin indicates postoperative serum calcitonin concentrations after pentagastrin
stimulation.

cleidoid musculature. Transient hypoparathyroidism was usually mild and short-lasting. Ten patients exhibited delayed closure of the wound attributable to a lymphatic fistula in six patients. All fistulae were conservatively treated and closed spontaneously within two weeks. In one patient, excessive postoperative bleeding required surgical intervention. Two patients developed unilateral palsy of the recurrent nerve.

Discussion
Bilateral neck dissection/sporadic form
Postoperative serum CT levels of two of eight patients were
within normal limits both basally and after pentagastrin stimulation whereas the values of six patients were above the normal
range after stimulation.
Bilateral neck dissection/MEN 2
Both patients exhibit elevated serum CT levels after pentagastrin stimulation.
Group results
It should be noted that a marked postoperative reduction of
the basal and stimulated CT levels was achieved in all patients,
even in those eight with persistently abnormal pentagastrin
stimulation tests.
The Table lists the lymph node compartments involved in all
38 patients. MTC was detected in the lateral neck and mediastinum in two of four patients with normal postoperative pentagastrin stimulation tests. A high percentage of patients with elevated CT levels had lymph node metastases in the lateral neck
and the mediastinal compartments.
Postoperatively, several patients had complications which
were mostly transient in nature. Most common were cutaneous
nerve lesions which were transient and attributable to the meticulous dissection over a wide distance, compression by retractors, and similar factors. The loss of cutaneous nerve function
was only partial; function was generally regained within the first
three months after hospital discharge.
The second most common side effect, permanent hypoparathyroidism, was observed in only one patient. Intraoperatively, it was difficult to preserve the vascular pedicle of at least
one parathyroid gland due to excessive scarring caused by previous operations. In these cases, the glandular tissue was identified by analysis of frozen sections and replanted into the stemo-
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MTC is a rare disease with characteristic biological features.
National and intemational tumor registries facilitate research efforts to expand our knowledge of these biological properties
(10,11). However, little experience has been gained in the successful treatment of occult metastatic MTC. There is clear evidence that measurements of the specific tumor marker CT permit the evaluation of the completeness and the success of any
surgical intervention (12-16). Elevated basal or pentagastrinstimulated CT values after primary surgery (thyroidectomy) indicate persistent disease. In most cases, occult metastases undetectable by available imaging techniques are responsible for abnormal CT levels. Selective venous catheterization can aid in
the site-selection for further treatment. Elevated postoperative
CT levels have been demonstrated to influence the prognosis
(5). If it is possible to normalize serum CT concentrations, a favorable outcome can be expected (17). Tisell et al (7) have used
microsurgical techniques to achieve complete lymph node dissections. Experience to date suggests that this method holds the
greatest potential for cure. Following this rationale, we treated
28 patients with elevated pentagastrin-stimulated CT levels who
had already received a total thyroidectomy as the primary therapy. The metastases could not be detected with available imaging techniques. In four of these 28 patients, microsurgical lymph
node dissection achieved a biochemical cure as evidenced by
the normalization of the pentagastrin stimulation test. The complication rate was not excessive. Cutaneous nerve lesions which
comprised the majority of postoperative complications usually
disappeared within several months after surgery (18). Further
follow-up is necessary to determine whether a potential increase
in cure rates by the microsurgical lymph node dissection outweighs the possible complications of surgery. Tisell's technique
resulted in normalization of basal and pentagastrin-stimulated
CT levels even years after the primary diagnosis of metastatic
MTC, and a significant reduction of the tumor burden is
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achieved by the extensive microsurgical lymph node dissection.
Whether or not we will observe the long-term cures reported by
Tisell et al (7) remains to be determined because of the limited
postoperative observation period.
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